Hormone replacement therapy. Risks, benefits, and costs
- PMID: 8219862
- PMCID: PMC2379850
Hormone replacement therapy. Risks, benefits, and costs
Abstract
Epidemiologic evidence on the risks and benefits of hormone replacement therapy (HRT) for postmenopausal women is accumulating. The apparent 50% reduction in risk of cardiovascular mortality could lead to universal HRT. Until a prospective, controlled trial is concluded, women must consider all the consequences of HRT. For the undecided, who would take HRT only to prevent osteoporosis, bone mass estimates might be warranted.
Similar articles
-
Benefits of hormone replacement therapy--overview and update.Int J Fertil Womens Med. 1997;42 Suppl 2:329-46. Int J Fertil Womens Med. 1997. PMID: 9397382 Review.
-
[Evidence of hormone replacement therapy for osteoporosis].Clin Calcium. 2008 Oct;18(10):1434-41. Clin Calcium. 2008. PMID: 18830040 Review. Japanese.
-
Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.Maturitas. 2005 May 16;51(1):8-14. doi: 10.1016/j.maturitas.2005.02.019. Maturitas. 2005. PMID: 15883103
-
Benefits and risks of hormone/estrogen replacement.Nurs Clin North Am. 1996 Dec;31(4):815-25. Nurs Clin North Am. 1996. PMID: 8969341 Review.
-
A computer model to analyze the cost-effectiveness of hormone replacement therapy.Int J Technol Assess Health Care. 1999 Spring;15(2):352-65. Int J Technol Assess Health Care. 1999. PMID: 10507194
Cited by
-
Cost effectiveness of coronary heart disease prevention strategies in adults.Pharmacoeconomics. 1998 Jul;14(1):27-48. doi: 10.2165/00019053-199814010-00004. Pharmacoeconomics. 1998. PMID: 10182193 Review.
-
Prevention of osteoporosis: cost-effectiveness of different pharmaceutical treatments.Osteoporos Int. 1996;6(4):265-75. doi: 10.1007/BF01623384. Osteoporos Int. 1996. PMID: 8883114 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources